Treatment

prophylactic donor lymphocyte infusion (DLI) clinical trials

1 indexed studies · 0 currently recruiting

Active not recruitingPHASE2
Early Prophylactic Donor Lymphocyte Infusion After Allo-HSCT for Patients With AML
This study looks at giving an extra treatment called donor lymphocyte infusion (DLI) early after a stem cell transplant for people with acute myeloid leukaemia (AML). The aim is to see if this helps stop the leukaemia from coming back.
For: Acute Myeloid Leukemia
France